HIGHLIGHTS
- who: Hong Li and collaborators from the Capital Medical University, China have published the research: Clinical cure rate of inactive HBsAg carriers with HBsAg 238 dB/m) had higher tendency than that in patients without steatosis. Moderate steatosis definitively benefits the HBsAg clearance in patients treated with PEG-IFN. @@
ACRONYMS
- ADV: Adefovir
- ALT: Aminotransferase
- CAP: Controlled attenuation parameter
- CHB: Chronic hepatitis b
- ETV: Treated with entecavir
- HBV: Hepatitis b virus
- HCV: Hepatitis c virus
- HIV: Human immunodeficiency virus
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.